Polk County’s largest hospital system is putting ivermectin to the test — administering the parasite drug to COVID patients with mild to moderate symptoms as part of a nationwide study to determine its effectiveness.
Lakeland Regional Health has joined a study led by the National Institute of Health, the Duke University Clinical Research Institute and the Vanderbilt University Medical Institute that officially launched in June.
Timothy Regan, the hospital’s chief medical officer, said in a statement that in order to be eligible for the study, participants must be 30 years of age or older, have had a positive COVID-19 test within the past 10 days, and have at least two symptoms of the illness for seven days or less.
(Visited 171 times, 1 visits today)
